Who’s sharing their clinical trial results?
FDAAA 2007 is a law that requires certain clinical trials to report results. After a long wait, it effectively came into force for all trials due after January 2018. The FDA are not publicly tracking compliance. So we are, here.
Trials reported
16135 out of 20855
Percent reported
77.4%
US Govt could have imposed fines of at least
$62,988,588,969
Fines claimed by US Govt
$0
Showing 1 to 100 of 11,310 entries
| Status | Sponsor | Trial ID | Title | Completion date | Days overdue |
|---|---|---|---|---|---|
| overdue | Corcept Therapeutics | NCT03437941 | Phase 1/2a Dose-Escalation and Expansion Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of CORT125281 With Enzalutamide in Patients With Metastatic Castration-Resistant Prostate Cancer | 2023-01-09 | 31 |
| overdue | Columbia University | NCT04528459 | Computer-Assisted Surgery for Internal Fixation of Peritrochanteric Femur Fractures: A Randomized Controlled Study | 2023-01-09 | 31 |
| overdue | Quantum Genomics SA | NCT04857840 | A Phase 3, Double-blind, Placebo-controlled and Open-label Efficacy and Long-term Safety Study of Firibastat (QGC001) Administered Orally, Once Daily, for Up to 48 Weeks in Patients With Difficult-to-treat/Resistant Hypertension. | 2023-01-09 | 31 |
| overdue | ExoStat Medical, Inc. | NCT05499624 | Safety & Efficacy of Oral Mucosal Carbon Dioxide Pressure (POMCO2) Measurement to Monitor Tissue Perfusion | 2023-01-09 | 31 |
| overdue | PQ Bypass, Inc. | NCT04130737 | The PQ Bypass Pivotal IDE Intra-arterial Stent Graft Study for Occlusive and Re-stenotic Fem-pop Revascularization - 2 Trial: TORUS 2 | 2023-01-06 | 34 |
| overdue | Madrigal Pharmaceuticals, Inc. | NCT04197479 | A 52-Week, Phase 3 Study to Evaluate Safety and Biomarkers of Resmetirom (MGL-3196) in Patients With Non-alcoholic Fatty Liver Disease (NAFLD) (MAESTRO-NAFLD-1) | 2023-01-06 | 34 |
| overdue | Casa Colina Hospital and Centers for Healthcare | NCT05225220 | Multimodal Investigation of Post COVID-19 in Females: A Pilot Study | 2023-01-06 | 34 |
| overdue | Evolution Optiks Limited | NCT05259163 | An Evaluation of the LFR-260 Against a Traditional Phoropter in Visual Acuity Testing | 2023-01-06 | 34 |
| overdue | Tandem Diabetes Care, Inc. | NCT05422053 | Control-IQ Technology for High Insulin Users With Type 1 Diabetes (Higher-IQ) | 2023-01-06 | 34 |
| reported-late | Memorial Sloan Kettering Cancer Center | NCT00382200 | Phase I/II Study of Decitabine and All-Trans Retinoic Acid (Tretinoin) for Patients With Myelodysplastic Syndromes [pACT] | 2023-01-05 | 27 |
| overdue | Hackensack Meridian Health | NCT02338232 | Pilot Study of Telmisartan (Micardis) For the Prevention of Acute Graft vs. Host Disease Post Allogeneic Hematopoietic Stem Cell Transplantation [pACT] | 2023-01-05 | 35 |
| reported-late | Children's Hospital Medical Center, Cincinnati | NCT03568708 | Primary Ovarian Insufficiency: Phenotype and Optimal Treatment | 2023-01-05 | 21 |
| overdue | Donald O Mutti, OD, PhD | NCT03669146 | The Enhancement Via Accommodation (EVA) Study | 2023-01-05 | 35 |
| reported-late | Mark O'Connor | NCT05197829 | Glycemic Optimization On Discharge From the Emergency Room | 2023-01-05 | 32 |
| overdue | Harpoon Therapeutics | NCT03872206 | A Phase 1/2a Open-label, Multicenter, Dose Escalation and Dose Expansion Study of the Safety, Tolerability, and Pharmacokinetics of HPN536 in Patients With Advanced Cancers Associated With Mesothelin Expression Who Have Failed Standard Available Therapy | 2023-01-04 | 36 |
| overdue | NGM Biopharmaceuticals, Inc | NCT04210245 | Evaluation of Efficacy, Safety and Tolerability of NGM282 (Aldafermin) in a Phase 2b, Randomized, Double-blind, Placebo-controlled, Multi-center Study in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis (ALPINE 4) | 2023-01-04 | 36 |
| overdue | Nicole Fram M.D. | NCT04521140 | Assessing eFficacy and Safety of DEXTENZA 0.4 mg inseRt in Conjunction With Topical Prednisolone Acetate 1% Treating Pain, and inflamMation Following Corneal Transplant Surgery Compared to Topical Prednisolone Acetate 1%. | 2023-01-04 | 36 |
| overdue | ImmunityBio, Inc. | NCT04927884 | Open-Label Phase 1b/2 Study of Sacituzumab Govitecan-Hziy Plus Chemoimmunotherapy for the Treatment of Subjects With Advanced Triple-Negative Breast Cancer After Prior Therapy | 2023-01-04 | 36 |
| overdue | BUZZZ Pharmaceuticals Limited | NCT05007808 | Phase 2 Multicenter, Double-blind, Randomized, Parallel-Group, Vehicle-Controlled Study to Evaluate the Efficacy, Safety, and Local Tolerability of G001 in Patients With Osteoarthritis (OA) of the Knee | 2023-01-04 | 36 |
| overdue | Baylor Research Institute | NCT02830204 | Surgical Implantation of TRAnscatheter vaLve in Native Mitral Annular Calcification (SITRAL) Study [pACT] | 2023-01-03 | 37 |
| overdue | C. Kent Osborne, MD | NCT04123704 | A Phase II Study of Sitravatinib in Metastatic, Pre-treated, Triple Negative Breast Cancer | 2023-01-03 | 37 |
| overdue | BioMed Valley Discoveries, Inc | NCT04488003 | A Two-Part, Phase II, Multi-center Study of the ERK Inhibitor Ulixertinib (BVD-523) for Patients With Advanced Malignancies Harboring MEK or Atypical BRAF Alterations | 2023-01-03 | 37 |
| overdue | Assiut University | NCT05024682 | Pulsed Radiofrequency Versus Pulse Dose Pulsed Radiofrequency of the Pudendal Nerve in Patients With Pudendal Neuralgia | 2023-01-03 | 37 |
| reported-late | University of Maryland, Baltimore | NCT05162027 | Erenumab as a Therapeutic Approach for the Management of Painful Chronic Temporomandibular Disorders (TMD) | 2023-01-03 | 13 |
| reported-late | University of Minnesota | NCT03326141 | Community-based Intervention Effects on Older Adults' Physical Activity and Falls (R01) | 2023-01-01 | 27 |
| overdue | Regeneris Medical | NCT03297177 | Use Of Autologous Stem Cell Use In Neurological Non-neoplastic Disorders And Disease | 2023-01-01 | 39 |
| overdue | Massachusetts General Hospital | NCT03097575 | Bronchial NIR Image-guided Resection, Mapping And Targeted Lymphadenectomy for Lung Lesions [pACT] | 2023-01-01 | 39 |
| overdue | University of Turin, Italy | NCT03379441 | A Randomized Phase II Study of Pembrolizumab (MK-3475) as Maintainance Therapy in Patients With Unresectable Stage III Non-small Cell Lung Cancer Treated With Definitive Chemo-radiotherapy | 2023-01-01 | 39 |
| overdue | Ochsner Health System | NCT03752073 | Comparison of Two Mechanical Methods of Outpatient Ripening of the Cervix | 2023-01-01 | 39 |
| overdue | North Carolina State University | NCT04453943 | Modeling, Optimization, and Control Methods for a Personalized Hybrid Walking Exoskeleton | 2023-01-01 | 39 |
| overdue | Wilfrid Laurier University | NCT04468516 | Treatment of Chronic Back Pain With Focused Vibroacoustic Stimulation | 2023-01-01 | 39 |
| overdue | Huashan Hospital | NCT04547621 | The Combination of Hypofractionated Stereotactic Radiotherapy and Chemoradiotherapy Using Intensity-Modulated Radiotherapy for Newly Diagnosed Glioblastoma Multiforme: A Prospective, Single-Center, Single-Arm Phase II Clinical Trial | 2023-01-01 | 39 |
| overdue | Massachusetts Eye and Ear Infirmary | NCT04735263 | Dark Adaptation as an Early Indicator of Response to Statin Therapy for Intermediate AMD | 2023-01-01 | 39 |
| overdue | Vivasure Medical Limited | NCT04818541 | Early Feasibility Study of the Vivasure PerQseal® Closure Device System After Use of the Impella Device for Cardiogenic Shock or Protected Percutaneous Coronary Intervention | 2023-01-01 | 39 |
| overdue | Institute for Clinical and Experimental Medicine | NCT04974684 | Direct Oral Anticoagulant Therapy With the HeartMate 3 LVAD: A Pilot Study | 2023-01-01 | 39 |
| overdue | Shanghai YingLi Pharmaceutical Co. Ltd. | NCT05274997 | A Single-arm, Phase II Study to Evaluate the Efficacy and Safety of Linperlisib (YY-20394) Monotherapy in Patients With Relapsed or Refractory Peripheral T/NK Cell Lymphoma | 2023-01-01 | 39 |
| overdue | Andrew Meltzer | NCT05467007 | Urgent Care Management of Respiratory Illness Enabled With Novel Testing Pathway (URGENT): A Randomized Control Trial of Respiratory PCR Versus Standard Care | 2023-01-01 | 39 |
| overdue | Parc de Salut Mar | NCT05531903 | High-density Activation Mapping of the Slow Pathway During Sinus Rhythm: a New and Simple Method to Guide Catheter Ablation in Patients With Typical Atrioventricular Nodal Reentrant Tachycardia | 2023-01-01 | 39 |
| reported-late | National Cancer Institute (NCI) | NCT02535312 | Phase I Study of TRC102 in Combination With Cisplatin and Pemetrexed in Patients With Advanced Solid Tumors / Phase II Study of TRC102 With Pemetrexed in Patients Refractory to Pemetrexed and Cisplatin or Carboplatin [pACT] | 2022-12-31 | 12 |
| overdue | Monica Thakar | NCT02100891 | Phase 2 Solid Tumor Immunotherapy Trial Using HLA-Haploidentical Transplant and Donor Natural Killer Cells: The STIR Trial [pACT] | 2022-12-31 | 40 |
| overdue | On-X Life Technologies, Inc. | NCT00291525 | Prospective Randomized On-X Anticoagulation Clinical Trial (PROACT) [pACT] | 2022-12-31 | 40 |
| overdue | Zofia Piotrowska | NCT02446704 | Phase I/II Study of Olaparib and Temozolomide in Patients With Recurrent Small Cell Lung Cancer Following Failure of Prior Chemotherapy [pACT] | 2022-12-31 | 40 |
| overdue | New York Medical College | NCT02558972 | Northera Improves Postural Tachycardia Syndrome (POTS) and Postural [pACT] | 2022-12-31 | 40 |
| overdue | SynerGene Therapeutics, Inc. | NCT02340117 | Phase II Study of Combined Targeted p53 Gene Therapy (SGT-53) Plus Gemcitabine/Nab-Paclitaxel for Treatment of Metastatic Pancreatic Cancer [pACT] | 2022-12-31 | 40 |
| reported-late | Dana-Farber Cancer Institute | NCT02795858 | A Phase II Study of Ramucirumab With Somatostatin Analog Therapy in Patients With Advanced, Progressive Carcinoid Tumors [pACT] | 2022-12-31 | 3 |
| overdue | Pentax Medical | NCT02514525 | Multi-center Clinical Study to Evaluate the C2 CryoBalloon Focal Ablation System for the Treatment of Patients With Previously Untreated Dysplastic Barrett's Epithelium [pACT] | 2022-12-31 | 40 |
| overdue | CURE Digestive Diseases Research Center | NCT03065465 | Randomized Controlled Trial (RCT) of Standard Endoscopic Hemostasis Compared to OVESCO for Severe Non-variceal UGI Hemorrhage [pACT] | 2022-12-31 | 40 |
| overdue | University of Minnesota | NCT01950234 | Treatment of Progressive Forms of Multiple Sclerosis With Pulsed ACTH (Acthar Gel) [pACT] | 2022-12-31 | 40 |
| overdue | Craig L Slingluff, Jr | NCT02305186 | A Randomized Multicenter Ib/II Study to Assess the Safety & Immunological Effect of Chemoradiation Therapy in Combination With Pembrolizumab Compared to CRT Alone Resectable/Borderline Resectable Pancreatic Cancer [pACT] | 2022-12-31 | 40 |
| overdue | Massachusetts General Hospital | NCT01681264 | Effect of Guanfacine on Opioid-induced Hyperalgesia (OIH) and Tolerance [pACT] | 2022-12-31 | 40 |
| overdue | InSightec | NCT02289560 | A Continued Access Study to Evaluate the Effectiveness and Safety of ExAblate Transcranial MRgFUS Thalamotomy Treatment of Medication Refractory Essential Tremor Subjects [pACT] | 2022-12-31 | 40 |
| overdue | McNeel Eye Center | NCT02921009 | Study of Effectiveness and Safety of Transepithelial Collagen Cross-linking at Varying Fluence Levels. [pACT] | 2022-12-31 | 40 |
| reported-late | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | NCT02203695 | Phase II Randomized Placebo-Controlled Double-Blind Study of Salvage Radiation Therapy (SRT) Plus Placebo Versus SRT Plus Enzalutamide in Men With High-Risk PSA-Recurrent Prostate Cancer After Radical Prostatectomy [pACT] | 2022-12-31 | 23 |
| overdue | Anica Crnkovic | NCT02653742 | Prospective, Randomized, Allocation-Concealed, Blinded Study Designed to Compare Ketorolac Sublingual and Fentanyl Intranasal in Pain Control for Bilateral Myringotomy and Tubes (BMT) Placement in Children [pACT] | 2022-12-31 | 40 |
| overdue | University of Colorado, Denver | NCT02973594 | Pulse Reduction On Beta-blocker and Ivabradine Therapy [pACT] | 2022-12-31 | 40 |
| reported-late | InSightec | NCT01827904 | A Pivotal Study to Evaluate the Effectiveness and Safety of ExAblate Transcranial MRgFUS Thalamotomy Treatment of Medication Refractory Essential Tremor Subjects [pACT] | 2022-12-31 | 38 |
| overdue | Nationwide Children's Hospital | NCT03276065 | Randomized Controlled Trial of Laser Hair Depilation in Adolescents With Pilonidal Disease | 2022-12-31 | 40 |
| overdue | The Lowy Medical Research Institute Limited | NCT03321916 | Controlled Pilot Study for Safety and Efficacy of Subthreshold Photothermal Therapy for Patients With Macular Telangiectasia (MacTel) Type 2 | 2022-12-31 | 40 |
| overdue | Blythedale Children's Hospital | NCT03387449 | Adaptive Arm Training for Children With Hemiplegia | 2022-12-31 | 40 |
| overdue | Gillette Children's Specialty Healthcare | NCT03107546 | Comparison of Scar Formation in Syndactyly Release Surgery With Full Thickness Skin Graft Versus Skin Graft Substitute | 2022-12-31 | 40 |
| overdue | Karolinska University Hospital | NCT03395613 | Prophylactic Use of a Negative Pressure Incision Management System in Infrainguinal Vascular Surgery - A Multicentre Randomized Controlled Trial | 2022-12-31 | 40 |
| overdue | Orthofix Inc. | NCT03339492 | Prospective, Randomized, Double-Blind, Placebo Controlled Study to Evaluate the Safety and Efficacy of Pulsed Electromagnetic Field (PEMF) Therapy as an Adjunctive Treatment to Surgical Repair of Full Thickness Rotator Cuff Tears | 2022-12-31 | 40 |
| reported-late | Rabih A. Chaer | NCT02758847 | Evaluation of Paclitaxel in Patients With CLI (Critical Limb Ischemia) and Femoropopliteal Occlusive Disease Treated With DCB Angioplasty [pACT] | 2022-12-31 | 1 |
| overdue | Dana-Farber Cancer Institute | NCT03170648 | Ear Acupuncture During Chemotherapy Infusion for Breast Cancer, a Feasibility Study | 2022-12-31 | 40 |
| overdue | Cell>Point LLC | NCT01394679 | A Multicenter Phase 3 Study Comparing the Diagnostic Accuracy of 99mTc EC DG SPECT/CT Versus 18F FDG PET/CT for Diagnosing and Staging Patients Who Have Clinical and Radiological (CT) Evidence Consistent With a Diagnosis of Lung Cancer | 2022-12-31 | 40 |
| reported-late | National Cancer Institute (NCI) | NCT02974621 | A Randomized Phase 2 Trial of Cediranib and Olaparib Compared to Bevacizumab in Patients With Recurrent Glioblastoma Who Have Not Received Prior VEGF Therapy | 2022-12-31 | 9 |
| overdue | Leonard-Meron Biosciences, Inc. | NCT02901717 | Efficacy and Safety of Mino-Lok Therapy (MLT) in Combination With Systemic Antibiotics in the Treatment of Catheter-Related or Central Line-Associated Bloodstream Infection | 2022-12-31 | 40 |
| overdue | National Institute of Allergy and Infectious Diseases (NIAID) | NCT03315078 | Lentiviral Gene Transfer for Treatment of Children Older Than 2 Years of Age With X-Linked Severe Combined Immunodeficiency [pACT] | 2022-12-31 | 40 |
| overdue | Cell>Point LLC | NCT01899833 | A Prospective, Open-label, Multicenter Study With Blinded Over-reading Characterizing the Efficacy and Safety of 99mTc-EC-DG in the Evaluation of Coronary Artery Disease (CAD) | 2022-12-31 | 40 |
| overdue | Dr. B. Catharine. Craven | NCT03113994 | The Efficacy and Safety of Rosuvastatin for Modifying Bone Mass and Cardiometabolic Disease Outcomes | 2022-12-31 | 40 |
| overdue | National Heart Centre Singapore | NCT03102723 | Platelet Inhibition to Target Reperfusion Injury: The PITRI Trial | 2022-12-31 | 40 |
| overdue | Collaborative Medicinal Development Pty Limited | NCT03136809 | A Treatment Continuation Study for Patients With Amyotrophic Lateral Sclerosis/Motor Neuron Disease Who Have Successfully Completed Study CMD-2016-001 | 2022-12-31 | 40 |
| overdue | Infectious Diseases Physicians, Inc. | NCT03426761 | Dalbavancin For The Treatment Of Gram Positive Osteomyelitis Or Joint Infections Including Prosthetic Hip Or Knee Infections | 2022-12-31 | 40 |
| overdue | Chimerix | NCT02863991 | Oral ONC201 in Relapsed/Refractory Multiple Myeloma [pACT] | 2022-12-31 | 40 |
| overdue | University of California, San Diego | NCT03099005 | Effect of Cannabis Administration and Endocannabinoids on HIV Neuropathic Pain Primary Study - Phase 2 | 2022-12-31 | 40 |
| overdue | University of California, Davis | NCT03461445 | A Pilot Study to Evaluate Impact on Neurological Side Effects (Cognition, Memory, and Tremor) in Elderly (Age>65) Patients | 2022-12-31 | 40 |
| overdue | InSightec | NCT00147056 | A Study to Evaluate the Safety and Feasibility of Transcranial MRI-Guided Focused Ultrasound Surgery in the Treatment of Brain Tumors [pACT] | 2022-12-31 | 40 |
| overdue | Chimerix | NCT03485729 | A Phase II Study of ONC201 in Recurrent or Metastatic Type II Endometrial Cancer | 2022-12-31 | 40 |
| overdue | University of Maryland, Baltimore | NCT03538340 | Randomized, Single-Blinded, Controlled Trial Using Intraoperative Cryoanalgesia for Extended Pain Management Following Thoracotomy: ICE Study | 2022-12-31 | 40 |
| overdue | Fresno Community Hospital and Medical Center | NCT03554811 | Early Rehabilitation Using Functional Electrical Stimulation Assisted Supine Cycling Effect on Muscle Mass, Strength, Biomarkers, and Functional Outcomes as Compared With Conventional Exercise and Early Mobilization Alone in Critically Ill Patients in the Intensive Care Unit | 2022-12-31 | 40 |
| overdue | VA Palo Alto Health Care System | NCT03551678 | Novel Strategies to Combat Post-Traumatic Osteoarthritis (PTOA): Gait Retraining to Reduce Joint Loading, Inflammation, and PTOA Risk | 2022-12-31 | 40 |
| overdue | Fabio Iwamoto, MD | NCT03557359 | A Phase II, Open Label, Single Arm Study of Nivolumab for Recurrent or Progressive IDH Mutant Gliomas With Prior Exposure to Alkylating Agents | 2022-12-31 | 40 |
| overdue | University of Colorado, Denver | NCT02157974 | Assessment of Hepatic Glucose and Fat Regulation in Overweight Adolescent Girls [pACT] | 2022-12-31 | 40 |
| overdue | New York City Health and Hospitals Corporation | NCT03576820 | Intranasal Lidocaine to Treat Pediatric Migraine in the Emergency Department | 2022-12-31 | 40 |
| overdue | Ohio State University Comprehensive Cancer Center | NCT03583424 | A Phase I/II Trial of Venetoclax and BEAM Conditioning Followed by Autologous Stem Cell Transplantation for Patients With Primary Refractory Non-Hodgkin Lymphoma | 2022-12-31 | 40 |
| overdue | Columbia University | NCT03585114 | Prostate Cancer Monitoring Using [18F]DCFPyL and Blood Based Biomarkers | 2022-12-31 | 40 |
| reported-late | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | NCT03603002 | Studying the Pathologic and Immunologic Response After Ablative Radiation in Stage I Non-Small Cell Lung Cancer | 2022-12-31 | 29 |
| overdue | Cortendo AB | NCT03621280 | An Open-label Extension Study of Levoketoconazole (2S,4R-ketoconazole) in the Treatment of Endogenous Cushing's Syndrome | 2022-12-31 | 40 |
| overdue | Edesa Biotech Inc. | NCT03680131 | A Randomized, Double-Blind, Vehicle-Controlled, Sample Size Adaptive Design Study to Evaluate the Safety and Efficacy of Topically Applied EB01 Cream in Healthy Adult Volunteers and Adult Subjects With Chronic Allergic Contact Dermatitis | 2022-12-31 | 40 |
| overdue | Soo Lim | NCT03717194 | A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, to Evaluate the Effect of Ertugliflozin on Cardiac Function in Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control and Stage B Heart Failure | 2022-12-31 | 40 |
| overdue | Frontier Biotechnologies Inc. | NCT03719664 | A Phase 2, Multicenter, Three-part Study to Establish the Dosage, Safety and Antiviral Activity of Combination Therapy With Albuvirtide and 3BNC117 as Long-Acting Maintenance Therapy in Virologically Suppressed Subjects With HIV-1 Infection | 2022-12-31 | 40 |
| overdue | MedeonBio, Inc. | NCT03758222 | A Clinical Study to Evaluate the Safety and Feasibility (Including First in Human) of the XFLO EXPANDER SYSTEM (EXPANDER-1) | 2022-12-31 | 40 |
| overdue | Montana State University | NCT03768713 | A Randomized, Double-Blind, Placebo-Controlled Study to Determine the Effect of Suvorexant (Belsomra®) on Sympathetic Neural Activity and Baroreflex Function in Patients With Chronic Insomnia | 2022-12-31 | 40 |
| overdue | Stephanie Shimizu | NCT03770286 | Treatment of Interproximal Carious Lesions on Primary Molar Teeth With SDF and Super Floss Application Versus SDF Without Super Floss Versus Fluoride Varnish Alone: a Pilot Phase 3 Randomized Controlled Trial | 2022-12-31 | 40 |
| overdue | Shirley Ryan AbilityLab | NCT03773406 | Timing of Transcranial Direct Current Stimulation (tDCS) Combined With Speech and Language Therapy (SLT): An Intervention Development Study for Aphasia | 2022-12-31 | 40 |
| overdue | National Taiwan University Hospital Hsin-Chu Branch | NCT03793387 | Preoperative Versus Intraoperative Transbronchial Dye Localization for Small Pulmonary Nodule : A Prospective Randomized Trial | 2022-12-31 | 40 |
| overdue | Corcept Therapeutics | NCT03818256 | A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Miricorilant (CORT118335) in Obese Adult Patients With Schizophrenia or Bipolar Disorder and Recent Weight Gain While Taking Antipsychotic Medications (GRATITUDE) | 2022-12-31 | 40 |
| overdue | Columbia University | NCT03824275 | 18F-DCFPyL Positron Emission Tomography (PET)/Computed Tomography (CT) in Men With Prostate Cancer | 2022-12-31 | 40 |
| overdue | Forsyth Medical Center | NCT03844542 | Therapeutic Plasma Exchange in the Treatment of Sepsis Associated Multi-Organ Failure [SAMOF-TPE] | 2022-12-31 | 40 |
| overdue | National Baromedical Services | NCT03843671 | A Phase II Randomized Sham-Controlled Trial With Allocation Concealment and Blinded Patients and Assessors, Investigating Hyperbaric Oxygen as a Radiation Sensitizer for Locally Advanced Squamous Cell Carcinoma of the Oropharynx and Larynx | 2022-12-31 | 40 |